Send mail to Author

Patient-reported outcomes with risankizumab versus fumaric acid esters in systemic therapy-naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______   _    _     _  __     ___       _____     ___    
 /_   _// | || | ||  | |/ //   / _ \\    / ___//   / _ \\  
   | ||   | || | ||  | ' //   / //\ \\   \___ \\  / //\ \\ 
  _| ||   | \\_/ ||  | . \\  |  ___  ||  /    // |  ___  ||
 /__//     \____//   |_|\_\\ |_||  |_|| /____//  |_||  |_||
 `--`       `---`    `-` --` `-`   `-` `-----`   `-`   `-`
 


Back to frontdoor view

OPUS4 Logo